Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Lentigo

• TCA 15% Chemical Peel for Improvement in Hand Lentigines
• Effectiveness of Epidermal Growth Factor-containing Ointment on the Solar Lentigines
• Effectiveness and Safety of Isobutylamido-thiazolyl-resorcinol Cream 0.2% for Melasma and Facial Hyperpigmentation
• Prospective Study of Ingenol Mebutate for Non-invasive Lentigo Melanoma of the Face
• Photodynamic Therapy for Lentigo Maligna Using 5-aminolevulinic Acid Nanoemulsion as a Light Sensitizing Cream
• Topical Corticosteroids on the Incidence of Postinflammatory Hyperpigmentation After QsNdYAG Laser
• The Effect of Topical Anesthetics on Patients' Pain and Operative Experience During Treatment With QSwitched Laser
• Radiotherapy or Imiquimod in Complex Lentigo Maligna
• Comparative Study of the Therapy of Solar Lentigines With a Q-switched Rubin Laser Versus a Bleaching Cream
• A Fixed Triple Combination Cream for Solar Lentigines Associated to Cryotherapy
• Relevance of Imiquimod as Neo-adjuvant Treatment to Reduce Excision Size and the Risk of Intralesional Excision in Lentigo Malignant of the Face
• Effect of Topical Imiquimod on Lentigo Maligna
• Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Stage IV Melanoma
• Imiquimod to Detect Residual Lesions and Prevent Recurrence of Lentigo Maligna
• Solar Lentigines Treatment With the Triple Combination Cream
• Dinaciclib in Treating Patients With Stage IV Melanoma
• Combination Therapy With Imiquimod Cream 5% and Tazarotene Cream 0.1% for the Treatment of Lentigo Maligna
• AZD2171 in Treating Patients With Recurrent or Stage IV Melanoma